SYNB:NYE-Putnam Biorevolution ETF (USD)

ETF | Others |

Last Closing

USD 32.7875

Change

+0.05 (+0.15)%

Market Cap

USD 5.43M

Volume

1.36K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.05 (-0.23%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.16 (-0.27%)

USD 35.41B
DFAC Dimensional U.S. Core Equity 2..

-0.08 (-0.24%)

USD 29.38B
DTB DTE Energy Company 2020 Series

+0.31 (+1.46%)

USD 26.58B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 25.69B
JPST JPMorgan Ultra-Short Income ET..

-0.03 (-0.06%)

USD 25.59B
GBTC Grayscale Bitcoin Trust (BTC)

+0.02 (+0.04%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

-0.02 (-0.02%)

USD 13.04B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 12.23B
DFUV Dimensional US Marketwide Valu..

-0.03 (-0.07%)

USD 10.93B

ETFs Containing SYNB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.67% 72% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.67% 68% D+ 61% D-
Trailing 12 Months  
Capital Gain 19.51% 69% C- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.51% 63% D 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.95% 75% C 56% F
Dividend Return 4.95% 70% C- 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.49% 67% D+ 87% B+
Risk Adjusted Return 76.28% 86% B+ 88% B+
Market Capitalization 5.43M 13% F 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.